Related references
Note: Only part of the references are listed.Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients
Toshio Watanabe et al.
GUT (2014)
Aspirin for Primary Prevention of Cardiovascular Events: Meta-Analysis of Randomized Controlled Trials and Subgroup Analysis by Sex and Diabetes Status
Manling Xie et al.
PLOS ONE (2014)
Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study
Ikue Watari et al.
BMC GASTROENTEROLOGY (2013)
Rebamipide inhibits indomethacin-induced small intestinal injury: Possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5
Tetsuya Tanigawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan
Yuji Nadatani et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
High Mobility Group Box 1 Promotes Small Intestinal Damage Induced by Nonsteroidal Anti-Inflammatory Drugs through Toll-Like Receptor 4
Yuji Nadatani et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Small Intestinal Injury Caused by NSAIDs/Aspirin: Finding New from Old
T. Arakawa et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Terminal-Restriction Fragment Length Polymorphism (T-RFLP) Analysis for Changes in the Gut Microbiota Profiles of Indomethacin- and Rebamipide-Treated Mice
Hirotsugu Imaeda et al.
DIGESTION (2012)
Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase
Tetsuya Tanigawa et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2011)
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study
Hiroki Endo et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Aspirin-induced small bowel injuries and the preventive effect of rebamipide
Kazuhiro Mizukami et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Rebamipide: a gastrointestinal protective drug with pleiotropic activities
Yuji Naito et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid
Toshio Watanabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment
Edgardo Smecuol et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Present status and strategy of NSAIDs-induced small bowel injury
Kazuhide Higuchi et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Small Bowel Injury by Low-Dose Enteric-Coated Aspirin and Treatment With Misoprostol: A Pilot Study
Toshio Watanabe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study
Yasumasa Niwa et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent
T. Watanabe et al.
GUT (2008)
Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change
I. M. Gralnev et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: A randomized, multicenter, controlled trial - STORM STUDY
Soo-Heon Park et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2007)
Rebamipide reduces delay in gastric ulcer healing in cyclooxygenase-2-deficient mice
T Watanabe et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells
Y Nagano et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
15th anniversary of rebamipide: Looking ahead to the new mechanisms and new applications
T Arakawa et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils
T Watanabe et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers
T Akamatsu et al.
DIGESTIVE DISEASES AND SCIENCES (2002)